Thomas Kryza

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 8

Top Venues

Nature chemical biology

Histopathology

Nature reviews. Cancer

Science advances

University of Queensland

Université Francois-Rabelais de Tours Bibliothèque Universitaire de Sciences-Pharmacie (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Queensland Feb 14 2018

Australia

Research Officer :: mater research institute

Queensland University of Technology Mar 01 2016 - Jun 30 2017

Australia

Teaching assistant - Demonstrator :: Sciences - Cellular biology

Université Francois-Rabelais de Tours Bibliothèque Universitaire de Sciences-Pharmacie Oct 01 2011 - Nov 14 2013

France

Teaching assistant :: Biology

INSERM Sep 01 2010 - Nov 14 2013

France

PhD Student :: U1100

Education History

Université Francois-Rabelais de Tours Bibliothèque Universitaire de Sciences-Pharmacie Sep 01 2010 - Nov 14 2013

France

PHD :: Health

Université Lille 1 Sep 01 2007 - Jun 30 2009

France

MSC :: Biology

Publications

Madeline Gough, Cheng Liu, Bhuvana Srinivasan, Lisa Wilkinson, Louisa Dunk, Yuanhao Yang, Veronika Schreiber, Haitham W Tuffaha, Thomas Kryza, John D Hooper, Sunil R Lakhani, Cameron E Snell
Improved concordance of challenging human epidermal growth factor receptor 2 dual in-situ hybridisation cases with the use of a digital image analysis algorithm in breast cancer. Histopathology (2023)
Srilakshmi Srinivasan, Thomas Kryza, Jyotsna Batra, Judith A Clements
Remodelling of the tumour microenvironment by the kallikrein-related peptidases. Nature reviews. Cancer 22 (4) (2022)
Nathalie Bock, Thomas Kryza, Ali Shokoohmand, Joan Röhl, Akhilandeshwari Ravichandran, Marie-Luise Wille, Colleen C Nelson, Dietmar Werner Hutmacher, Judith A Clements
In vitro engineering of a bone metastases model allows for study of the effects of antiandrogen therapies in advanced prostate cancer. Science advances 7 (27) (2021)
Thomas Kryza, Tashbib Khan, Scott Lovell, Brittney S Harrington, Julia X Yin, Sean Porazinski, Marina Pajic, Hannu Koistinen, Juha K Rantala, Tobias Dreyer, Viktor Magdolen, Ute Reuning, Yaowu He, Edward William Tate, John D Hooper
Substrate-biased activity-based probes identify proteases that cleave receptor CDCP1. Nature chemical biology 17 (7) (2021)
Tashbib Khan, Thomas Kryza, Nicholas J Lyons, Yaowu He, John D Hooper
The CDCP1 Signaling Hub: A Target for Cancer Detection and Therapeutic Intervention. Cancer research 81 (9) (2021)
Brian W-C Tse, Thomas Kryza, Mei-Chun Yeh, Ying Dong, Kamil A Sokolowski, Carina Walpole, Tobias F Dreyer, Johanna Felber, Jonathan Harris, Viktor Magdolen, Pamela J Russell, Judith A Clements
KLK4 Induces Anti-Tumor Effects in Human Xenograft Mouse Models of Orthotopic and Metastatic Prostate Cancer. Cancers 12 (12) (2020)
Samaneh Farashi, Thomas Kryza, Jyotsna Batra
Pathway Analysis of Genes Identified through Post-GWAS to Underpin Prostate Cancer Aetiology. Genes 11 (5) (2020)
Thomas Kryza, Nathalie Bock, Scott Lovell, Anja Rockstroh, Melanie L Lehman, Adam Lesner, Janaththani Panchadsaram, Lakmali Munasinghage Silva, Srilakshmi Srinivasan, Cameron E Snell, Elizabeth D Williams, Ladan Fazli, Martin Gleave, Jyotsna Batra, Colleen Nelson, Edward W Tate, Jonathan Harris, John D Hooper, Judith A Clements
The molecular function of kallikrein-related peptidase 14 demonstrates a key modulatory role in advanced prostate cancer. Molecular oncology 14 (1) (2019)

Thomas Kryza.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Thomas Kryza